Loopbaan van Ingmar Bruns
Eerdere bekende functies van Ingmar Bruns
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 02-11-2020 | 17-11-2021 |
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12-10-2017 | - |
Opleiding van Ingmar Bruns
| Universität zu Lübeck | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Duitsland | 2 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Beurs
- Insiders
- Ingmar Bruns
- Ervaring
